Stryker Stock Performance
| SYK Stock | USD 336.85 0.00 0.00% |
Stryker has a performance score of 8 on a scale of 0 to 100. The entity has a beta of 0.69, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Stryker's returns are expected to increase less than the market. However, during the bear market, the loss of holding Stryker is expected to be smaller as well. Stryker right now has a risk of 1.23%. Please validate Stryker total risk alpha, downside variance, as well as the relationship between the Downside Variance and rate of daily change , to decide if Stryker will be following its existing price patterns.
Risk-Adjusted Performance
8 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Stryker are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite quite unfluctuating basic indicators, Stryker may actually be approaching a critical reversion point that can send shares even higher in May 2024. ...more
Actual Historical Performance (%)
One Day Return 0.67 | Five Day Return 2.05 | Year To Date Return 13.82 | Ten Year Return 332.93 | All Time Return 404.5 K |
Forward Dividend Yield 0.0096 | Payout Ratio 0.2925 | Last Split Factor 2:1 | Forward Dividend Rate 3.2 | Dividend Date 2024-04-30 |
| Stryker dividend paid on 31st of January 2024 | 01/31/2024 |
1 | Disposition of tradable shares by Yin Becker of Stryker subject to Rule 16b-3 | 03/21/2024 |
2 | Acquisition by Yin Becker of 3060 shares of Stryker at 339.77 subject to Rule 16b-3 | 03/22/2024 |
3 | Walgreens Boots Q2 Earnings Top Estimates, EPS View Down | 03/28/2024 |
4 | Reasons to Add Cardinal Health to Your Portfolio Now | 04/04/2024 |
5 | Hospital Furniture Market size is set to grow by USD 7.83 billion from 2023-2027, Rise in international accreditation by hospitals boost the market, Technavio | 04/10/2024 |
6 | Vladimir Putins forces suffer catastrophic losses in horror day for Russian army | 04/11/2024 |
7 | Subdural Hematoma Treatment Market To Register a Positive CAGR By 2032 DataHorizzon Research | 04/15/2024 |
8 | Institutional investors in Stryker Corporation lost 3.0 percent last week but have reaped the benefits of longer-term growth | 04/16/2024 |
9 | Henry Schein Global Presence Aids, Macroeconomic Woes Stay | 04/17/2024 |
10 | Stryker Corporation On An Uptrend Could Fundamentals Be Driving The Stock | 04/18/2024 |
11 | Stryker Earnings Expected to Grow What to Know Ahead of Next Weeks Release | 04/23/2024 |
| Begin Period Cash Flow | 1.8 B |
Stryker |
Stryker Relative Risk vs. Return Landscape
If you would invest 31,065 in Stryker on January 26, 2024 and sell it today you would earn a total of 2,620 from holding Stryker or generate 8.43% return on investment over 90 days. Stryker is generating 0.138% of daily returns assuming volatility of 1.2253% on return distribution over 90 days investment horizon. In other words, 10% of stocks are less volatile than Stryker, and above 98% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Stryker Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Stryker's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Stryker, and traders can use it to determine the average amount a Stryker's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1126
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | SYK | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.23 actual daily | 10 90% of assets are more volatile |
Expected Return
| 0.14 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.11 actual daily | 8 92% of assets perform better |
Based on monthly moving average Stryker is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Stryker by adding it to a well-diversified portfolio.
Stryker Fundamentals Growth
Stryker Stock prices reflect investors' perceptions of the future prospects and financial health of Stryker, and Stryker fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Stryker Stock performance.
| Return On Equity | 0.18 | ||||
| Return On Asset | 0.0687 | ||||
| Profit Margin | 0.15 % | ||||
| Operating Margin | 0.24 % | ||||
| Current Valuation | 137.8 B | ||||
| Shares Outstanding | 380.47 M | ||||
| Price To Earning | 63.07 X | ||||
| Price To Book | 7.00 X | ||||
| Price To Sales | 6.35 X | ||||
| Revenue | 20.5 B | ||||
| Gross Profit | 11.65 B | ||||
| EBITDA | 4.95 B | ||||
| Net Income | 3.17 B | ||||
| Cash And Equivalents | 1.84 B | ||||
| Cash Per Share | 2.98 X | ||||
| Total Debt | 12.99 B | ||||
| Debt To Equity | 0.88 % | ||||
| Current Ratio | 2.00 X | ||||
| Book Value Per Share | 48.92 X | ||||
| Cash Flow From Operations | 3.71 B | ||||
| Earnings Per Share | 8.24 X | ||||
| Market Capitalization | 127.42 B | ||||
| Total Asset | 39.91 B | ||||
| Retained Earnings | 16.77 B | ||||
| Working Capital | 4.6 B | ||||
| Current Asset | 1.15 B | ||||
| Current Liabilities | 707.5 M | ||||
About Stryker Performance
To evaluate Stryker Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Stryker generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Stryker Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Stryker market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Stryker's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 237.59 | 145.86 | |
| Return On Tangible Assets | 0.16 | 0.10 | |
| Return On Capital Employed | 0.12 | 0.21 | |
| Return On Assets | 0.08 | 0.11 | |
| Return On Equity | 0.17 | 0.19 |
Things to note about Stryker performance evaluation
Checking the ongoing alerts about Stryker for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Stryker help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Over 79.0% of the company shares are owned by institutional investors | |
| Latest headline from zacks.com: Stryker Earnings Expected to Grow What to Know Ahead of Next Weeks Release |
- Analyzing Stryker's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Stryker's stock is overvalued or undervalued compared to its peers.
- Examining Stryker's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Stryker's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Stryker's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Stryker's stock. These opinions can provide insight into Stryker's potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Stryker. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing. For more information on how to buy Stryker Stock please use our How to buy in Stryker Stock guide.You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Complementary Tools for Stryker Stock analysis
When running Stryker's price analysis, check to measure Stryker's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Stryker is operating at the current time. Most of Stryker's value examination focuses on studying past and present price action to predict the probability of Stryker's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Stryker's price. Additionally, you may evaluate how the addition of Stryker to your portfolios can decrease your overall portfolio volatility.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |
Is Stryker's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Stryker. If investors know Stryker will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Stryker listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.027 | Dividend Share 3.05 | Earnings Share 8.24 | Revenue Per Share 53.999 | Quarterly Revenue Growth 0.118 |
The market value of Stryker is measured differently than its book value, which is the value of Stryker that is recorded on the company's balance sheet. Investors also form their own opinion of Stryker's value that differs from its market value or its book value, called intrinsic value, which is Stryker's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Stryker's market value can be influenced by many factors that don't directly affect Stryker's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Stryker's value and its price as these two are different measures arrived at by different means. Investors typically determine if Stryker is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Stryker's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.